Magellan Health (NASDAQ: MGLN) reported Q4 EPS of $1.39, $0.56 better than the analyst estimate of $0.83. Revenue for the quarter came in at $1.27 billion versus the consensus estimate of $1.22 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.